A landmark study presented at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting has revealed something extraordinary. Women taking GLP-1 drugs like Ozempic and Wegovy were roughly 30% less likely to develop breast cancer – a finding that is reshaping how doctors think about these blockbuster weight-loss medications. What the Study Found Researchers […]
Medically reviewed by Dr. Ajit Kumar, MD (Medicine) | Member, Editorial Board, Medimadad Health Editorial Team Millions of people are taking Ozempic, Wegovy, and Mounjaro with impressive results. But a growing body of research is asking a question that very few people in the weight loss conversation are talking about: why do so many patients […]
🦺Medically Written & Reviewed By Dr. Ajit Kumar, MD (Medicine) — Lifetime Member, Indian Medical Association. About the Author | Editorial Policy Everyone knows Ozempic and Wegovy for one reason: weight loss. But in 2026, a wave of new research is revealing something that is catching even doctors off guard. These GLP-1 receptor agonist drugs […]
🦺Medically Written & ReviewedBy Dr. Ajit Kumar, MD (Medicine) — Lifetime Member, Indian Medical Association. About the Author | Editorial Policy Weight loss surgery dominated obesity treatment for over two decades. Surgeons could not keep up with demand. Hospital waiting lists stretched months long. Then, almost overnight, the operating rooms started getting quieter. The reason […]
🦺Medically Written & ReviewedBy Dr. Ajit Kumar, MD (Medicine) — Lifetime Member, Indian Medical Association. About the Author | Editorial Policy For millions of people managing type 2 diabetes or considering GLP-1 therapy for weight loss, injections have always been the biggest barrier. That barrier may now be coming down. Novo Nordisk has launched an […]
🦺Medically Written & ReviewedBy Dr. Ajit Kumar, MD (Medicine) — Lifetime Member, Indian Medical Association. About the Author | Editorial Policy Two of the most prescribed weight loss drugs in the world – Ozempic (semaglutide) and Mounjaro (tirzepatide) – are now being scrutinised for a side effect that doctors rarely mention in the consultation room: […]
🦺Medically Written & ReviewedBy Dr. Ajit Kumar, MD (Medicine) — Lifetime Member, Indian Medical Association. About the Author | Editorial Policy A new weight loss drug is generating some of the most striking clinical trial results ever seen in the field of obesity medicine. Survodutide — developed by Boehringer Ingelheim and Zealand Pharma — produced […]
